Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

0.4127
-0.0007-0.17%
Post-market: 0.4125-0.0002-0.05%18:52 EDT
Volume:118.31K
Turnover:49.19K
Market Cap:9.10M
PE:-0.47
High:0.4200
Open:0.4060
Low:0.4060
Close:0.4134
Loading ...

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025

ACCESSWIRE
·
12 Dec 2024

Acurx Pharmaceuticals Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Dec 2024

BRIEF-FDA Provides Positive Feedback On Acurx's CMC Plan For Phase 3

Reuters
·
09 Dec 2024

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. Difficile Infection Based on Recent FDA and Ema Communications

THOMSON REUTERS
·
09 Dec 2024

Acurx Pharmaceuticals Inc - FDA Provides Positive Feedback on Acurx's Cmc Plan for Phase 3

THOMSON REUTERS
·
09 Dec 2024

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

PR Newswire
·
09 Dec 2024

Trump's crypto advocacy steers businesses away from traditional treasury assets

Reuters
·
05 Dec 2024

Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now

Zacks
·
28 Nov 2024

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ACCESSWIRE
·
27 Nov 2024

MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000 -- Barrons.com

Dow Jones
·
23 Nov 2024

Bitcoin Briefly Eclipses $99K—Why Investors Just Can't Get Enough

Investopedia
·
22 Nov 2024

Acurx Pharmaceuticals Shares Slide 17% After Disclosing Bitcoin Investment

Dow Jones
·
21 Nov 2024

BRIEF-Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

Reuters
·
20 Nov 2024

Acurx Pharmaceuticals Inc: Approved Purchase of up to $1 Mln in Bitcoin to Hold as a Treasury Reserve Asset

THOMSON REUTERS
·
20 Nov 2024

Acurx supported, participated in Peggy Lillis CDI symposium

TIPRANKS
·
18 Nov 2024

Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural Cdi Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update

THOMSON REUTERS
·
18 Nov 2024

Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update

PR Newswire
·
18 Nov 2024

Acurx Pharmaceuticals Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
14 Nov 2024

Acurx Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024